Literature DB >> 6831194

Eye movement disorders in multiple sclerosis and optic neuritis.

J P Reulen, E A Sanders, L A Hogenhuis.   

Abstract

Horizontal saccadic and smooth pursuit eye movements were studied in 84 patients with multiple sclerosis (MS) and 21 patients with optic neuritis (ON). The MS patients were clinically classified as 'definite', 'probable', or 'possible'; subclinical eye movement disorder was found in 80 per cent of the definite, 74 per cent of the probable and 60 per cent of the possible category. Five of the ON patients (25 per cent) showed a subclinical eye movement deficit; these 5 were young patients with a recent history of ON. In a group of 27 MS patients with symptoms of spinal cord involvement only, 14 showed subclinical oculomotor disorder indicating the involvement of cerebral structures in the demyelination process. A study of the correlation between specific eye movement parameters and results of visual evoked response (VER) tests revealed that saccadic latency or smooth pursuit abnormalities are not correlated with prolonged VER latencies (P-100 peak latency). This indicates that lesions beyond the primary visual pathway contribute substantially to both parameters of oculomotor dysfunction. A significant correlation was found between prolonged saccadic latency and smooth pursuit deficit. An explanation for this finding based on functional aspects of the saccadic and smooth pursuit systems and their mutual interaction is presented. The occurrence of internuclear ophthalmoplegia (INO) is significantly related to an increase of saccadic latency. This finding indicates that demyelination in the patients manifesting INO may not be restricted exclusively to one or both medial longitudinal fasciculi, but may extend to other brainstem structures which are functionally involved in the programming of saccades. The findings confirm the value of standardized objective examination of eye movements in the detection and clarification of subclinical lesions in the central nervous system of patients with an early diagnosis of MS or ON.

Entities:  

Mesh:

Year:  1983        PMID: 6831194     DOI: 10.1093/brain/106.1.121

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  13 in total

Review 1.  The ocular manifestations of multiple sclerosis. 2. Abnormalities of eye movements.

Authors:  D Barnes; W I McDonald
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-10       Impact factor: 10.154

2.  Evaluation of the smooth pursuit tests in multiple sclerosis patients.

Authors:  Magdalena Jozefowicz-Korczynska; Anna Maria Pajor
Journal:  J Neurol       Date:  2011-03-29       Impact factor: 4.849

3.  Role of saccadic analysis in the diagnosis of multiple sclerosis in the era of magnetic resonance imaging.

Authors:  G Tedeschi; S Allocca; A Di Costanzo; A Diano; V Bonavita
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-08       Impact factor: 10.154

4.  Computerised eye-movement processor for clinical applications: basic considerations and design.

Authors:  J P Reulen; R van Heuningen; G Tiesinga; J E Bos
Journal:  Med Biol Eng Comput       Date:  1986-03       Impact factor: 2.602

5.  Central nervous system involvement in optic neuritis.

Authors:  E A Sanders; J P Reulen; L A Hogenhuis
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-03       Impact factor: 10.154

6.  Latency of visually evoked saccadic eye movements. II. Temporal properties of the facilitation mechanism.

Authors:  J P Reulen
Journal:  Biol Cybern       Date:  1984       Impact factor: 2.086

7.  Exploring Retinal Blood Vessel Diameters as Biomarkers in Multiple Sclerosis.

Authors:  Dragana Drobnjak Nes; Pål Berg-Hansen; Sigrid A de Rodez Benavent; Einar A Høgestøl; Mona K Beyer; Daniel A Rinker; Nina Veiby; Mia Karabeg; Beáta Éva Petrovski; Elisabeth G Celius; Hanne F Harbo; Goran Petrovski
Journal:  J Clin Med       Date:  2022-05-31       Impact factor: 4.964

8.  Neuro-ophthalmologic aspects of multiple sclerosis: Using eye movements as a clinical and experimental tool.

Authors:  Annette Niestroy; Janet C Rucker; R John Leigh
Journal:  Clin Ophthalmol       Date:  2007-09

9.  Oculomotor control in Gilles de la Tourette syndrome.

Authors:  E L Bollen; R A Roos; A P Cohen; R B Minderaa; J P Reulen; B J Van de Wetering; T C Van Woerkom; O J Buruma
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-08       Impact factor: 10.154

10.  The value of measuring saccadic eye movement in the investigation of non-compressive myelopathy.

Authors:  M C Pitt; J M Rawles
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-10       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.